GoldenGolden
GT Medical Technologies

GT Medical Technologies

GT Medical Technologies has developed a unique therapeutic approach to the treatment of brain tumors.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

November 2020
GT Medical Technologies raises a $16,000,000 series B round from BlueStone Venture Partners, MVM and MedTech Venture Partners.
January 2019
GT Medical Technologies raises a $10,000,000 series A round from BlueStone Venture Partners and MedTech Venture Partners.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
May 25, 2021
BioSpace
Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with GT Medical Technologies, Inc., to develop Tumor Treating Fields (TTFields) together with GT Medical Technologies' GammaTile Surgically Targeted Radiation Therapy (STaRT) for treatment of recurrent glioblastoma (GBM). Novocure's TTFields are electric fields that disrupt cancer cell division.
FinSMEs
November 23, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.